Clearpoint Neuro, Inc. (CLPT)
NASDAQ:CLPT
Total Valuation
ClearPoint Neuro has a market cap or net worth of $277.95M. The enterprise value is $291.05M.
Market Cap$277.95M
Enterprise Value$291.05M
Share Statistics
ClearPoint Neuro has 29,663,876 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,663,876
Owned by Insiders3.29%
Owned by Institutions8.39%
Financial Efficiency
ClearPoint Neuro’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -27.56%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-27.56%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee321.49K
Profits Per Employee-222.09K
Employee Count115
Asset Turnover0.38
Inventory Turnover1.71
Valuation Ratios
The current PE Ratio of ClearPoint Neuro is ―. ClearPoint Neuro’s PEG ratio is -0.53.
PE Ratio―
PS Ratio10.48
PB Ratio13.82
Price to Fair Value13.82
Price to FCF-15.84
Price to Operating Cash Flow-11.09
PEG Ratio-0.53
Income Statement
In the last 12 months, ClearPoint Neuro had revenue of 36.97M and earned -25.54M in profits. Earnings per share was -0.90.
Revenue36.97M
Gross Profit22.69M
Operating Income-24.16M
Pretax Income-25.48M
Net Income-25.54M
EBITDA-21.93M
Earnings Per Share (EPS)-0.90
Cash Flow
In the last 12 months, operating cash flow was -23.93M and capital expenditures -522.00K, giving a free cash flow of -24.45M billion.
Operating Cash Flow-23.93M
Free Cash Flow-24.45M
Free Cash Flow per Share-0.82
Dividends & Yields
ClearPoint Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.76
52-Week Price Change-14.43%
50-Day Moving Average11.94
200-Day Moving Average14.17
Relative Strength Index (RSI)40.86
Average Volume (3m)987.96K
Important Dates
ClearPoint Neuro upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
ClearPoint Neuro as a current ratio of 5.91, with Debt / Equity ratio of 207.82%
Current Ratio5.91
Quick Ratio5.13
Debt to Market Cap0.13
Net Debt to EBITDA-0.56
Interest Coverage Ratio-10.12
Taxes
In the past 12 months, ClearPoint Neuro has paid 55.00K in taxes.
Income Tax55.00K
Effective Tax Rate>-0.01
Enterprise Valuation
ClearPoint Neuro EV to EBITDA ratio is -18.23, with an EV/FCF ratio of -16.35.
EV to Sales10.81
EV to EBITDA-18.23
EV to Free Cash Flow-16.35
EV to Operating Cash Flow-16.70
Balance Sheet
ClearPoint Neuro has $45.92M in cash and marketable securities with $58.23M in debt, giving a net cash position of -$12.31M billion.
Cash & Marketable Securities$45.92M
Total Debt$58.23M
Net Cash-$12.31M
Net Cash Per Share-$0.41
Tangible Book Value Per Share$0.23
Margins
Gross margin is 61.38%, with operating margin of -65.36%, and net profit margin of -69.08%.
Gross Margin61.38%
Operating Margin-65.36%
Pretax Margin-68.93%
Net Profit Margin-69.08%
EBITDA Margin-59.31%
EBIT Margin-65.36%
Analyst Forecast
The average price target for ClearPoint Neuro is $25.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$25.00
Price Target Upside-8.49% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast12.83%
EPS Growth Forecast-19.53%